[Nang Kuang] May 2026 Revenue Reaches NT$187 Million (Up 7.5% YoY)
Nang Kuang Pharmaceutical Co., Ltd. (TWSE: 1752) announced its financial results for May 2026, with monthly revenue rising 7.5% year-on-year to NT$186.76 million, indicating steady growth in the biotechnology and medical care sector.
📋 Article Processing Timeline
- 📰 Published: May 1, 2026 at 09:00
- 🔍 Collected: June 12, 2026 at 08:00 (1007h 0m after Published)
- 🤖 AI Analyzed: June 12, 2026 at 16:44 (8h 44m after Collected)
Company Code: 1752
Company Name: Nang Kuang Pharmaceutical Co., Ltd.
Industry: Biotechnology and Medical Care
Data Month: May 2026
Monthly Revenue: 186,759 thousand NTD (approx. 187 million NTD)
YoY Growth: +7.5%
Company Name: Nang Kuang Pharmaceutical Co., Ltd.
Industry: Biotechnology and Medical Care
Data Month: May 2026
Monthly Revenue: 186,759 thousand NTD (approx. 187 million NTD)
YoY Growth: +7.5%
FAQ
What is Nang Kuang's revenue for May 2026?
Nang Kuang's monthly revenue for May 2026 is NT$186,759 thousand (approx. NT$187 million).
What is the year-on-year growth rate for May 2026?
The year-on-year growth rate is +7.5% compared to the same period last year.
Which industry sector does Nang Kuang belong to?
Nang Kuang belongs to the Biotechnology and Medical Care sector.